NPI 1093738429: Open Payments
NPI 1093738429. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 19 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $106 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $196 |
| Abbott Laboratories | 3 | $179 |
| Janssen Pharmaceuticals, Inc | 5 | $160 |
| PFIZER INC. | 3 | $54 |
| Exact Sciences Corporation | 2 | $35 |
| Dexcom, Inc. | 1 | $21 |
Products named: FREESTYLE LIBRE 3, SPRAVATO, QULIPTA, EMBLAVEO, NURTEC ODT, ELIQUIS, Dexcom G6 Transmitter, Cologuard Collection Kit.
